These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Innate immunity in inflammatory bowel disease: state of the art. Hisamatsu T; Ogata H; Hibi T Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors, inflammation, metabolism and obesity. Fresno M; Alvarez R; Cuesta N Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616 [TBL] [Abstract][Full Text] [Related]
5. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Sell H; Eckel J Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):366-70. PubMed ID: 20473150 [TBL] [Abstract][Full Text] [Related]
6. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Tilg H; Moschen AR Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136 [TBL] [Abstract][Full Text] [Related]
8. Adipocytokines - novel link between inflammation and vascular function? Guzik TJ; Mangalat D; Korbut R J Physiol Pharmacol; 2006 Dec; 57(4):505-28. PubMed ID: 17229978 [TBL] [Abstract][Full Text] [Related]
9. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Tlaskalová-Hogenová H; Tucková L; Stepánková R; Hudcovic T; Palová-Jelínková L; Kozáková H; Rossmann P; Sanchez D; Cinová J; Hrncír T; Kverka M; Frolová L; Uhlig H; Powrie F; Bland P Ann N Y Acad Sci; 2005 Jun; 1051():787-98. PubMed ID: 16127016 [TBL] [Abstract][Full Text] [Related]
10. Adipose tissue inflammation in obesity and metabolic syndrome. Nishimura S; Manabe I; Nagai R Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868 [TBL] [Abstract][Full Text] [Related]
11. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Calabro P; Yeh ET Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046 [TBL] [Abstract][Full Text] [Related]
12. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127 [TBL] [Abstract][Full Text] [Related]
13. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Cario E Curr Opin Gastroenterol; 2008 Nov; 24(6):725-32. PubMed ID: 19122523 [TBL] [Abstract][Full Text] [Related]
16. Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Gil A; María Aguilera C; Gil-Campos M; Cañete R Br J Nutr; 2007 Oct; 98 Suppl 1():S121-6. PubMed ID: 17922949 [TBL] [Abstract][Full Text] [Related]
17. Targeting the innate immune system in pediatric inflammatory bowel disease. Schirbel A; Fiocchi C Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):33-41. PubMed ID: 21309670 [TBL] [Abstract][Full Text] [Related]
18. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Schäffler A; Schölmerich J; Salzberger B Trends Immunol; 2007 Sep; 28(9):393-9. PubMed ID: 17681884 [TBL] [Abstract][Full Text] [Related]
20. Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. Sonier B; Patrick C; Ajjikuttira P; Scott FW Int Rev Immunol; 2009; 28(6):414-45. PubMed ID: 19954357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]